FDA will review Eisai and Biogen’s Alzheimer’s treatment Leqembi with decision on full approval expected in early July

Study: Adjunctive Use of FDA-Approved CBD Formulation Reduces Seizures in Pediatric Patients With Rett Syndrome

Sanofi’s Tzield gains approval in China for T1D management

Capricor refutes FDA’s DMD deramiocel rejection in public statement

Health Canada approves Medison and Ipsen’s Bylvay to treat ALGS